aTyr Pharma ATYR Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivablesNetCurrent.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- aTyr Pharma (ATYR) reported other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) of $477K in Q1 2026.
- How has aTyr Pharma's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) changed year-over-year?
- aTyr Pharma's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) decreased by 51.7% year-over-year, from $988K to $477K.
- What is the long-term trend for aTyr Pharma's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- Over 5 years (2020 to 2025), aTyr Pharma's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) has grown at a -15.6% compound annual growth rate (CAGR), from $2.04M to $873K.